Urologic Diseases

0
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AM-Pharma
AM-PharmaNetherlands - Utrecht
2 programs
AquablationN/A1 trial
RezumN/A1 trial
Active Trials
NCT05169892RecruitingEst. Dec 2026
NCT05201131RecruitingEst. Dec 2026
M&
Merck & Co.RAHWAY, NJ
1 program
Audit-and-feedbackN/A1 trial
Active Trials
NCT04196777Completed525Est. Aug 2023
C
ColoplastAustralia - Mulgrave
1 program
Coloplast TFL DriveN/A1 trial
Active Trials
NCT06257368UnknownEst. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ColoplastColoplast TFL Drive
Merck & Co.Audit-and-feedback
AM-PharmaAquablation
AM-PharmaRezum

Clinical Trials (4)

Total enrollment: 525 patients across 4 trials

NCT06257368ColoplastColoplast TFL Drive

TFL Driven Urinary System Treatment Study

Start: Jul 2023Est. completion: Dec 2025
N/AUnknown
NCT04196777Merck & Co.Audit-and-feedback

Audit-and-feedback to Improve Antimicrobial-prescribing Among Urologists

Start: Aug 2022Est. completion: Aug 2023525 patients
N/ACompleted
NCT05169892AM-PharmaAquablation

Aquablation in Benign Prostatic Hyperplasia in Canada

Start: Oct 2019Est. completion: Dec 2026
N/ARecruiting
NCT05201131AM-PharmaRezum

Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).

Start: Oct 2019Est. completion: Dec 2026
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 525 patients
3 companies competing in this space